Belviq: the New FDA Approved Obesity-Fighting Drug

Jan.14 (Bloomberg) –- Arena Pharmaceuticals President & CEO Jack Lief and Eisai President & CEO Lonnel Coats discuss the new obesity-fighting drug, Belviq, how it works and the potential side effects with Mark Crumpton on Bloomberg Television's "Taking Stock." (Source: Bloomberg)
Is It Time to Buy Chinese Stocks?
15:26 - North Grove Capital founder Gabriel Wallach discusses the performance of Chinese equities and his investment strategy with Bloomberg's Scarlet Fu on "Bloomberg Markets." (Source: Bloomberg)
  • The $200 Nvidia Shield Is Taking on the PS4 and Xbox One
  • Google Announces New Feature 'Now on Tap'
  • Soaring Tanker Rates Show Oil Supply Glut Persists